Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
James T. D'Olimpio, MD, FACP, FAAH
Healthcare Provider Director of Supportive Oncology and the Palliative Care
North Shore University Hospital
The Monter Cancer Center
450 Lakeville Road
Lake Success, New York, United States
James T. D’Olimpio, MD, FACP, FAAHPM is the Director of Supportive/Palliative Oncology and leads the Cancer Pain and Symptom Control Service at North Shore University Hospital. He is also an Assistant Professor of Medicine at Hofstra/North Shore -LIJ School of Medicine. Dr. D’Olimpio has extensive experience in oncology research and treatment, focusing primarily on symptom management including cancer pain, chemotherapy induced peripheral neuropathy, sickle cell disease/painful crisis, and cancer anorexia/cachexia syndrome –the persistent fatigue, anorexia and weight loss associated with cancer.
He is an author of multiple professional and technical papers. He is on the Editorial Staff of The Journal of Pain and Symptom Management, The Journal of Hospice and Palliative Medicine, Cancer and is the Associate Section Editor in Symptom Assessment Management for the American Academy of Hospice and Palliative Medicine/PC-FACS. He was one of the first physicians in the country to become Board Certified in the fields of Internal Medicine, Medical Oncology and Hospice/Palliative Medicine. In addition, Dr. D’Olimpio is a member of the American College of Physicians, American Society of Clinical Oncology; American Academy of Hospice and Palliative Medicine; Multi-National Association for Supportive Care in Cancer (MASCC).
+myBinderRelated Content
-
Newborn Screening Guide for ParentsMost babies born in the United States ar...
-
Suvankar Majumdar, MDDr. Majumdar was born in Zambia, attende...
-
Lamia Barakat, PhDLamia P. Barakat, PhD, is the Director o...
-
Teens with Sickle Cell Disease Moving from Pediatric Care to Adult CareMoving from pediatric (children’s) car...
-
PCORI Board Approves $18 Million for Research on Sickle Cell DiseaseThe Patient-Centered Outcomes Research I...
-
Gene-Therapy Company Crispr Drops as FDA Puts Trial on HoldCrispr Therapeutics AG plunged after the...
-
Children’s MinnesotaChildren’s Cancer and Blood Disorders ...
